FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a method for generating radioiotopes to be used in nuclear medicine for producing pharmaceutical preparations administered into the patients. The declared method involves exposing a target to a deceleration radiation beam and extracting the generated radionuclides from the target by radiochemical approaches. The declared method is implemented by using the target and nuclear reactions in the above reactions in the target and causing generating the chemical nuclei different from the target chemicals. The deceleration radiation is generated by an electron beam at energy 40-60 MeV and average beam current 40 mcA in a radiator having a thickness of tenth to one radiation length of a radiator material. The target exposure duration makes one half-life period of the generated isotope T1/2.
EFFECT: declared invention provides higher specific activity of radionuclides for nuclear medicine.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING STRONTIUM-82 RADIONUCLIDE | 2015 |
|
RU2598089C1 |
| METHOD FOR OBTAINING AC-225 FROM RA-226 | 2020 |
|
RU2756621C1 |
| METHOD OF PRODUCING TERBIUM-149 RADIOISOTOPE | 2015 |
|
RU2600324C1 |
| METHOD FOR PRODUCING THORIUM (STARTING MATERIAL) RADIONUCLIDE FOR MAKING THERAPEUTIC PREPARATION BASED ON BISMUTH RADIONUCLIDE | 2001 |
|
RU2199165C1 |
| METHOD FOR PRODUCING TERBIUM-154 AND TERBIUM-155 RADIOISOTOPES | 2022 |
|
RU2793294C1 |
| METHOD OF PREPARING RADIONUCLIDE THORIUM-229 - STARTING MATERIAL FOR PREPARATION OF THERAPEUTIC AGENT BASED ON RADIONUCLIDE BISMUTH-213 | 2001 |
|
RU2210125C2 |
| METHOD OF PRODUCING RADIOISOTOPE I-123 | 2022 |
|
RU2800032C1 |
| WAY OF RECEPTION OF URANIUM-230 RADIONUCLIDE FOR THERAPY OF ONCOLOGIC DISEASES | 2008 |
|
RU2362588C1 |
| METHOD OF OBTAINING THORIUM-228 RADIONUCLIDE | 2012 |
|
RU2499311C1 |
| RADIONUCLIDE GENERATOR HAVING FIRST AND SECOND ATOMS OF THE FIRST ELEMENT | 2012 |
|
RU2630475C2 |
